Silence Therapeutics' CEO resigns
This article was originally published in Scrip
The RNAi-focused biotechnology company Silence Therapeutics (UK), has announced that Jeffery Vick has resigned as group CEO and left the company. The board of directors has appointed Iain Ross, currently non-executive chairman, as full-time chairman and group CEO with immediate effect. Jeremy Curnock Cook, a non-executive director, has been appointed senior independent non-executive director.